Patents by Inventor Peter Kuebler

Peter Kuebler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9023346
    Abstract: A method for treating acute ischemic stroke in a human comprises administering tenecteplase to the human in a total dose of about 0.05 to 0.5 mg/kg, given as (a) an initial bolus dose of about 0.015 to 0.15 mg/kg, followed by infusion of an amount equaling the total dose minus the initial dose over a period of about 50-90 minutes, or (b) a bolus. Also described are kits for carrying out this method.
    Type: Grant
    Filed: July 22, 2011
    Date of Patent: May 5, 2015
    Assignee: Genentech, Inc.
    Inventor: Peter Kuebler
  • Publication number: 20120164157
    Abstract: A method for treating acute ischemic stroke in a human comprises administering tenecteplase to the human in a total dose of about 0.05 to 0.5 mg/kg, given as (a) an initial bolus dose of about 0.015 to 0.15 mg/kg, followed by infusion of an amount equaling the total dose minus the initial dose over a period of about 50-90 minutes, or (b) a bolus. Also described are kits for carrying out this method.
    Type: Application
    Filed: July 22, 2011
    Publication date: June 28, 2012
    Applicant: Genentech, Inc.
    Inventor: Peter KUEBLER
  • Publication number: 20080107641
    Abstract: A method for treating acute ischemic stroke in a human comprises administering tenecteplase to the human in a total dose of about 0.05 to 0.5 mg/kg, given as (a) an initial bolus dose of about 0.015 to 0.15 mg/kg, followed by infusion of an amount equaling the total dose minus the initial dose over a period of about 50-90 minutes, or (b) a bolus. Also described are kits for carrying out this method.
    Type: Application
    Filed: August 1, 2007
    Publication date: May 8, 2008
    Inventor: Peter Kuebler